Skip to content
OpenCapital
Get started

Eton Pharmaceuticals, Inc. ETON Q1 2026 earnings

Reported May 14, 2026 · After market close

Revenue$24.3MBeat by $2.0MDiluted EPS$0.05Miss by $0.05
Revenue estimate$22.3M
EPS estimate$0.10

Next report

Aug 6, 2026 (In 3 weeks)
Revenue estimate$26.9M
EPS estimate$0.13

Financials

Q1 2026

Income statement

See full
Revenue$24.3M+40.4%
Gross profit$14.7M+49.4%
Operating income$2.4M+614%
Net income$1.6M+199%
EPS (diluted)$0.05+183%

Balance sheet

See full
Cash & equivalents$19.7M+12.9%
Total debt$31.3M+3.7%
Total equity$30.6M+25.2%
Total assets$97.7M+16.3%

Cash flow

See full
Operating cash flow$7.4M+254%
CapEx$75.0K—
Free cash flow$7.3M+251%

Valuation & ratios

Valuation

as of 07/10/26
See full
Market cap$1.02B+93.4%
Enterprise value$1.03B+89.8%
P/S11.8×+0.8×

Profitability

See full
Gross margin54.8%-3.7pp

Returns & leverage

See full
Debt / equity1×-0.2×
Current ratio1.2×-0.8×

Versus estimates

Revenue

Q1 2026$24.3MBeat by $2.0M
Q4 2025$21.3MBeat by $1.3MQ3 2025$22.5MBeat by $2.0MQ2 2025$18.9MMiss by $1.5MQ1 2025$17.3MBeat by $2.2MQ4 2024$11.6MMiss by $2.7M

Diluted EPS

Q1 2026$0.05Miss by $0.05
Q4 2025$0.05Miss by $0.07Q3 2025-$0.07Miss by $0.23Q2 2025-$0.10Miss by $0.09Q1 2025$0.07Miss by $0.02Q4 2024-$0.02In line

Ask the moment Eton Pharmaceuticals, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Eton Pharmaceuticals, Inc. report Q1 2026 earnings?
Eton Pharmaceuticals, Inc. (ETON) reported Q1 2026 earnings on May 14, 2026 after market close.
What were Eton Pharmaceuticals, Inc.'s Q1 2026 revenue and EPS?
Eton Pharmaceuticals, Inc. reported revenue of $24.3M and diluted EPS of $0.05 for Q1 2026.
Did Eton Pharmaceuticals, Inc. beat estimates in Q1 2026?
Revenue beat the consensus estimate of $22.3M by $2.0M. EPS missed the consensus estimate of $0.10 by $0.05.
How did Eton Pharmaceuticals, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 40.4% from $17.3M a year earlier and diluted EPS declined 28.6% from $0.07.
Where can I find Eton Pharmaceuticals, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001437749-26-017063) and the 10-Q periodic report (0001437749-26-017064) directly on SEC EDGAR. The filing index links above go to sec.gov.